Search
Now showing items 841-850 of 973
Papers presented at events
CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy
| Date Issued:
2023 | Copyright:
open access
Papers presented at events
Eficient large-scale point-of-care production of affordable anti-CD19 CAR-T Cells for leukemia immunotherapy
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Evaluation of the affinity between single-chain M971 antibody fragments and the CD22
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Consensus serineprotease toxin design as antigen and cross-immunization combined strategy for generation of broadly binding antibodies
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Upstream optimization of recombinant L-asparaginase production in E. coli for the treatment of Acute Lymphoblastic Leukemia
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Structural modeling of two anti-Acinetobacter baumannii monoclonal antibodies and the target surface protein
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Characterization of anti-PD-1 biosimilar monoclonal antibody candidates using established methodologies
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Optimizing sample preparation and nLC-MS/MS for mAB characterization
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Obtainment and characterization of TIM-3_ECD-FC in HEK293-T cells as an antigen for the selection of antibodies for antitumor immunotherapy
| Date Issued:
2024 | Copyright:
open access
Papers presented at events
Integration of the risk analysis techniques and Spearman correlation to support the decision making based in a risk approach of the upstream steps in a therapeutic protein pilot scale
| Date Issued:
2024 | Copyright:
open access